192 related articles for article (PubMed ID: 23949004)
1. Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.
Willerslev-Olsen A; Krejsgaard T; Lindahl LM; Bonefeld CM; Wasik MA; Koralov SB; Geisler C; Kilian M; Iversen L; Woetmann A; Odum N
Toxins (Basel); 2013 Aug; 5(8):1402-21. PubMed ID: 23949004
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome.
Vadivel CK; Willerslev-Olsen A; Namini MRJ; Zeng Z; Yan L; Danielsen M; Gluud M; Pallesen EMH; Wojewoda K; Osmancevic A; Hedebo S; Chang YT; Lindahl LM; Koralov SB; Geskin LJ; Bates SE; Iversen L; Litman T; Bech R; Wobser M; Guenova E; Kamstrup MR; Ødum N; Buus TB
Blood; 2024 Apr; 143(15):1496-1512. PubMed ID: 38170178
[TBL] [Abstract][Full Text] [Related]
3. Enterococcal eschars in cutaneous T-cell lymphoma tumors: a distinct clinical entity.
Duvic M; Feasel AM; Schwartz CA; Cather JC
Clin Lymphoma; 2000 Sep; 1(2):141-5. PubMed ID: 11707823
[TBL] [Abstract][Full Text] [Related]
4. Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins.
Woetmann A; Lovato P; Eriksen KW; Krejsgaard T; Labuda T; Zhang Q; Mathiesen AM; Geisler C; Svejgaard A; Wasik MA; Ødum N
Blood; 2007 Apr; 109(8):3325-32. PubMed ID: 17179233
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.
Krejsgaard T; Willerslev-Olsen A; Lindahl LM; Bonefeld CM; Koralov SB; Geisler C; Wasik MA; Gniadecki R; Kilian M; Iversen L; Woetmann A; Odum N
Blood; 2014 Jul; 124(5):761-70. PubMed ID: 24957145
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus Induces Signal Transducer and Activator of Transcription 5‒Dependent miR-155 Expression in Cutaneous T-Cell Lymphoma.
Willerslev-Olsen A; Gjerdrum LMR; Lindahl LM; Buus TB; Pallesen EMH; Gluud M; Bzorek M; Nielsen BS; Kamstrup MR; Rittig AH; Bonefeld CM; Krejsgaard T; Geisler C; Koralov SB; Litman T; Becker JC; Woetmann A; Iversen L; Odum N
J Invest Dermatol; 2021 Oct; 141(10):2449-2458. PubMed ID: 33862068
[TBL] [Abstract][Full Text] [Related]
7. Role of infectious agents in cutaneous T-cell lymphoma: facts and controversies.
Mirvish JJ; Pomerantz RG; Falo LD; Geskin LJ
Clin Dermatol; 2013; 31(4):423-431. PubMed ID: 23806159
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous T-cell lymphoma and Staphylococcus aureus colonization.
Nguyen V; Huggins RH; Lertsburapa T; Bauer K; Rademaker A; Gerami P; Guitart J
J Am Acad Dermatol; 2008 Dec; 59(6):949-52. PubMed ID: 18835065
[TBL] [Abstract][Full Text] [Related]
9.
Blümel E; Munir Ahmad S; Nastasi C; Willerslev-Olsen A; Gluud M; Fredholm S; Hu T; Surewaard BGJ; Lindahl LM; Fogh H; Koralov SB; Rahbek Gjerdrum LM; Clark RA; Iversen L; Krejsgaard T; Bonefeld CM; Geisler C; Becker JC; Woetmann A; Andersen MH; Buus TB; Ødum N
Oncoimmunology; 2020; 9(1):1751561. PubMed ID: 32363124
[No Abstract] [Full Text] [Related]
10. Endolysin Inhibits Skin Colonization by Patient-Derived Staphylococcus Aureus and Malignant T-Cell Activation in Cutaneous T-Cell Lymphoma.
Pallesen EMH; Gluud M; Vadivel CK; Buus TB; de Rooij B; Zeng Z; Ahmad S; Willerslev-Olsen A; Röhrig C; Kamstrup MR; Bay L; Lindahl L; Krejsgaard T; Geisler C; Bonefeld CM; Iversen L; Woetmann A; Koralov SB; Bjarnsholt T; Frieling J; Schmelcher M; Ødum N
J Invest Dermatol; 2023 Sep; 143(9):1757-1768.e3. PubMed ID: 36889662
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins.
Tokura Y; Heald PW; Yan SL; Edelson RL
J Invest Dermatol; 1992 Jan; 98(1):33-7. PubMed ID: 1728639
[TBL] [Abstract][Full Text] [Related]
12. Infectious agents in cutaneous T-cell lymphoma.
Mirvish ED; Pomerantz RG; Geskin LJ
J Am Acad Dermatol; 2011 Feb; 64(2):423-31. PubMed ID: 20692726
[TBL] [Abstract][Full Text] [Related]
13. Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion.
Jackow CM; Cather JC; Hearne V; Asano AT; Musser JM; Duvic M
Blood; 1997 Jan; 89(1):32-40. PubMed ID: 8978274
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.
Lindahl LM; Willerslev-Olsen A; Gjerdrum LMR; Nielsen PR; Blümel E; Rittig AH; Celis P; Herpers B; Becker JC; Stausbøl-Grøn B; Wasik MA; Gluud M; Fredholm S; Buus TB; Johansen C; Nastasi C; Peiffer L; Kubat L; Bzorek M; Eriksen JO; Krejsgaard T; Bonefeld CM; Geisler C; Mustelin T; Langhoff E; Givskov M; Woetmann A; Kilian M; Litman T; Iversen L; Odum N
Blood; 2019 Sep; 134(13):1072-1083. PubMed ID: 31331920
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous manifestations of Epstein-Barr virus-associated T-cell lymphoma.
Su IJ; Tsai TF; Cheng AL; Chen CC
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):685-92. PubMed ID: 8227539
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome.
Willerslev-Olsen A; Buus TB; Nastasi C; Blümel E; Gluud M; Bonefeld CM; Geisler C; Lindahl LM; Vermeer M; Wasik MA; Iversen L; Becker JC; Andersen MH; Gjerdrum LMR; Litvinov IV; Litman T; Krejsgaard T; Woetmann A; Ødum N
Blood Cancer J; 2020 May; 10(5):57. PubMed ID: 32409671
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
18. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma.
Gluud M; Pallesen EMH; Buus TB; Gjerdrum LMR; Lindahl LM; Kamstrup MR; Bzorek M; Danielsen M; Bech R; Monteiro MN; Blümel E; Willerslev-Olsen A; Lykkebo-Valløe A; Vadivel CK; Krejsgaard T; Bonefeld CM; Geisler C; Becker JC; Koralov SB; Iversen L; Litman T; Woetmann A; Ødum N
Blood; 2023 Jan; 141(2):180-193. PubMed ID: 36122387
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.
Willerslev-Olsen A; Krejsgaard T; Lindahl LM; Litvinov IV; Fredholm S; Petersen DL; Nastasi C; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Kilian M; Koralov SB; Odum N
Blood; 2016 Mar; 127(10):1287-96. PubMed ID: 26738536
[TBL] [Abstract][Full Text] [Related]
20. Advanced/aggressive CTCL: improving the efficacy of treatment.
Zinzani PL
G Ital Dermatol Venereol; 2012 Dec; 147(6):563-72. PubMed ID: 23149702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
